Leukemia limfoblastik akut Dokter Terbaik di Israel - TOP-20 dokter

Dr. Ram Ron bekerja di salah satu rumah sakit pendidikan publik terkemuka dan terbesar di Israel, Sourasky Medical Center (Ichilov), yang dikenal dengan perawatan pasien tingkat tinggi dan inovasi medisnya.

• Mengakses perawatan dan teknologi canggih di rumah sakit universitas terkemuka
• Menjadi bagian dari tim hematologi-onkologi multidisiplin yang komprehensif
• Mendapatkan manfaat dari pusat yang didedikasikan untuk perawatan pasien dan penelitian
• Bekerja di rumah sakit yang terakreditasi oleh Joint Commission International

Dr. Ron Ram telah melakukan beberapa ratus transplantasi sel induk, sebuah prosedur utama untuk leukemia limfoblastik akut, sebagai ahli hematologi-onkologi bersertifikat.

• Sertifikasi dewan dalam bidang hematologi dan onkologi medis
• Pelatihan selama fellowship Hematologi dan Onkologi di New York Medical College
• Publikasi lebih dari 30 artikel ilmiah tentang kondisi hematologi
• Penulis bab dalam buku teks medis

Dr. Ronit El Hasid telah melakukan lebih dari 300 transplantasi sumsum tulang dan darah tali pusat untuk anak-anak di Rumah Sakit Anak Dana Dwek.

• Kepala Departemen Onkohematologi dan Onkologi Anak
• 50+ publikasi dan 40+ laporan konferensi
• Anggota Asosiasi Hematologi Amerika
• Dilatih di Rumah Sakit City of Hope di Los Angeles

Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.

He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.

He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.

His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.

Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.

She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.

She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.

She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.

Dr. Michael Shapira mengkhususkan diri secara eksklusif dalam transplantasi sumsum tulang di Sourasky Medical Center – pemimpin dalam perawatan hematologi.

• Lulus dari sekolah kedokteran Hebrew University pada tahun 1999
• Spesialisasi dalam penyakit dalam di Hadassah Medical Center
• Dokter senior dalam Transplantasi Sumsum Tulang di Hadassah
• Lancar dalam bahasa Inggris dan Ibrani

Dr. Fredi Aviv membawa lebih dari 31 tahun praktik terfokus sebagai onkohematolog di Sourasky Medical Center terkemuka di Tel Aviv.

• Mengkhususkan diri secara eksklusif dalam kanker darah seperti leukemia dan limfoma
• Memiliki masa jabatan jangka panjang di rumah sakit akademik dan penelitian utama
• Menawarkan pengalaman mendalam baik dengan diagnosis awal maupun rencana perawatan yang kompleks
• Menyediakan akses ke terapi berbasis rumah sakit dan uji klinis terbaru

Dr. Dror Levin mengepalai departemen hematologi onkologi pediatrik di Sourasky Medical Center di Tel Aviv, salah satu rumah sakit terkemuka di Israel.

• Pakar senior dalam menangani gangguan darah dan kanker tulang pada anak-anak
• Terlatih dalam onkologi pediatrik di Schneider Children's Medical Center
• Spesialisasi dalam hematologi pediatrik, termasuk gangguan koagulasi pada bayi prematur
• Mempelajari pengobatan sarkoma di Rizzoli Orthopaedic Institute yang ternama di dunia
• Anggota aktif Masyarakat Hemato-Onkologi Pediatrik Israel

Dr. Herishanu telah dianugerahi berbagai penghargaan bergengsi atas penelitiannya mengenai leukemia limfositik kronis.

• Memiliki pengalaman medis lebih dari 30 tahun sebagai ahli hematologi
• Penulis sejumlah makalah penelitian yang telah diterbitkan
• Menjalani pelatihan hematologi di Tel Aviv Medical Center
• Anggota Asosiasi Hematologi Amerika dan Israel

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

Prof. Elad Jacoby, MD, heads the Pediatric Cell Therapy Center at Sheba Medical Center. He is the Medical Director of the Advanced Biotherapy Center. He is a pioneer of pediatric CAR T‑cell therapy in Israel. He led one of the first national leukemia programs. He has almost 20 years of clinical and research experience.

He specializes in CAR T‑cell therapy, bone marrow and stem cell transplantation, and high‑risk pediatric leukemias and lymphomas. He leads international clinical trials and has authored over 240 publications. His collaborations include Johns Hopkins Hospital and the U.S. National Cancer Institute. He is an Associate Professor at Tel Aviv University. He received his MD from Tel Aviv University, completed residency at Sheba Medical Center, and fellowships at Johns Hopkins and the National Cancer Institute. He is board‑certified in Pediatrics and in Pediatric Hematology and Oncology. He serves on the IBFM CAR T‑Cell Taskforce and the Sheba Institutional Review Board. He leads the integration of CAR T‑cell therapy with transplantation.

Profesor Zila Zuckerman spesialis dalam bidang hematologi dan transplantologi di Rambam Medical Center.

• Ahli dalam mengobati leukemia limfoblastik akut
• Spesialisasi dalam transplantologi untuk gangguan darah
• Profesor dengan pengalaman akademis dan klinis yang luas

Kepala Hematologi di Hadassah Medical Center – Profesor Ben-Yehuda memelopori terapi gen dan transplantasi sumsum tulang untuk leukemia limfoblastik akut.

• Menjalani pelatihan di Memorial Sloan-Kettering Cancer Center di New York
• Dekan wanita pertama di Fakultas Kedokteran Hadassah
• Spesialisasi dalam diagnostik molekuler dan imunologi
• Penerima penghargaan Healing with the Heart Award untuk perawatan pasien yang luar biasa

Diakui oleh Forbes sebagai salah satu dokter terbaik pada tahun 2018 – Dr. Stepensky telah melakukan lebih dari 3.500 transplantasi sumsum tulang di Hadassah Medical Center.

• 20 tahun spesialisasi dalam transplantasi sumsum tulang pediatrik
• Fokus pada penyakit kanker darah langka pada anak-anak
• Dikenal di kalangan pasien sebagai 'sosok yang mentransplantasikan kehidupan'
• Memimpin unit hematologi pediatrik yang berdedikasi

Dr. Ofer Spielberg adalah spesialis onkohematologi, yang berfokus pada kanker darah seperti leukemia.

• Bekerja di Pusat Medis Assuta
• Keahlian dalam onkohematologi, bidang yang didedikasikan untuk kanker darah
• Memberikan perawatan tertarget untuk leukemia limfoblastik akut